EcoDrugPlus

Heat Shock Protein Hsp 90-Alpha-Like

Ensembl ID : ENSNBRG00000021902
Gene Symbol: LOC102800076
3 Cross references
345 Possible Orthologues:

Heat Shock Protein Hsp 90-Beta-Like

Ensembl ID : ENSNBRG00000022156
Gene Symbol: LOC102789505
3 Cross references
339 Possible Orthologues:

Hepatocyte Growth Factor Receptor-Like

Ensembl ID : ENSNBRG00000014037
Gene Symbol: LOC102786510
3 Cross references
202 Possible Orthologues:

High Affinity Camp-Specific 3',5'-Cyclic Phosphodiesterase 7a-Like

Ensembl ID : ENSNBRG00000023477
Gene Symbol: LOC102791045
3 Cross references
227 Possible Orthologues:

High Affinity Nerve Growth Factor Receptor-Like

Ensembl ID : ENSNBRG00000004429
Gene Symbol: LOC102797767
3 Cross references
199 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSNBRG00000023628
Gene Symbol: LOC102783704
3 Cross references
509 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSNBRG00000014226
Gene Symbol: LOC102776899
2 Cross references
511 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSNBRG00000021892
Gene Symbol: HRH1
4 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSNBRG00000013209
Gene Symbol: HRH2
3 Cross references
182 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSNBRG00000005767
Gene Symbol: HRH2A
1 Cross references
189 Possible Orthologues:

Histone Deacetylase 10-Like

Ensembl ID : ENSNBRG00000019276
Gene Symbol: LOC102790899
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 11-Like

Ensembl ID : ENSNBRG00000017682
Gene Symbol: LOC102793587
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).